In recent years, the world has witnessed a profound cultural and scientific shift in the perception and understanding of
A psychedelics-focused drug development company is officially asking the Food and Drug Administration (FDA) to review an application to
A new article in the Journal of the American Medical Association (JAMA) suggests that state-regulated psychedelics are on a
The campaign behind a prospective California ballot initiative to legalize psychedelics filed a final revised measure with state officials
Bipartisan and bicameral congressional lawmakers have reached an agreement on a large-scale defense bill that contains a House GOP-led
The push toward mainstream legitimacy is largely what’s fueled the rise in dealmaking. Business deals, partnerships, and mergers in
Massachusetts activists say local election clerks across the state have certified that they turned in more than enough valid
The company expects to launch a Phase 2 study in the first quarter of 2024. Gilgamesh Pharmaceuticals announced the
Table of Contents Yarixa Ferrao, a 42-year-old in Los Angeles, was working as a personal trainer when she injured
In the realm of psychedelic mushrooms, Psilocybe natalensis stands out as a remarkable species. This intriguing mushroom, hailing from